Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-25 @ 7:18 PM
Study NCT ID:
NCT01226732
Status:
COMPLETED
Last Update Posted:
2022-03-08
First Post:
2010-10-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-18
First Submit QC Date:
None
Study First Post Date:
2010-10-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-06
Results First Submit QC Date:
None
Results First Post Date:
2015-01-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-03-08
Last Update Post Date Type:
ACTUAL